-The Times of India Broadening definition of rape is a good first step, but higher conviction rate is a must The government's move to make rape a gender-neutral crime is a welcome step towards harmonising current anomalies in laws relating to sexual offence. The proposed changes are aimed at broadening the definition of rape, so far restricted to penile and vaginal penetration. The replacement of the word 'rape' with 'sexual assault', a...

-The Hindu The Union Cabinet on Thursday approved a proposal to replace the word “rape” with the phrase “sexual assault”, making it a gender-neutral offence and identified acid attacks as a separate offence punishable by a maximum of ten years. Union Minister for Women & Child Development (WCD) Krishna Tirath confirmed that the Cabinet had given the go-ahead to the draft proposal. “Besides the two proposals that have been accepted, it has...

-The Hindu While government pushes for affirmative action in private industry, players differ on the methodology to be followed Even as P.L. Punia, Chairman, National Commission for Scheduled Castes said that reservations for marginalised communities in the private sphere should be mandated, industry members differed on the strategy for affirmative action. While everybody acknowledged the problems faced by marginalised communities and the need to find solutions, they did not agree on the way...

-The Hindu As the debate raged on the discrimination against children admitted under the Right to Education (RTE) Act in Oxford English School on Nandini Layout, the school management, which kept mum thus far, has finally come out with a clarification. Ajit Prabhu, correspondent of the school — where locks of hair of the children admitted under the RTE Act were cut to distinguish them from others — spoke to The Hindu...

-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...